These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 17855271)
1. Amino-terminal brain natriuretic peptide is related to the presence of diabetic polyneuropathy independently of cardiovascular disease. Jurado J; Ybarra J; Ferrandiz M; Comerma L; Pou JM Diabetes Care; 2007 Aug; 30(8):e86. PubMed ID: 17855271 [No Abstract] [Full Text] [Related]
2. Intensified multifactorial intervention in patients with type 2 diabetes and microalbuminuria: rationale and effect on late-diabetic complications. Gaede PH Dan Med Bull; 2006 Aug; 53(3):258-84. PubMed ID: 17092449 [No Abstract] [Full Text] [Related]
3. Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: no evidence for its occurrence in the era of intensive insulin therapy. Konduracka E; Gackowski A; Rostoff P; Galicka-Latala D; Frasik W; Piwowarska W Eur Heart J; 2007 Oct; 28(20):2465-71. PubMed ID: 17766928 [TBL] [Abstract][Full Text] [Related]
6. Multiple biomarkers and cardiovascular risk. Austin MJ; Heneghan MA N Engl J Med; 2008 Aug; 359(7):760-1; author reply 761. PubMed ID: 18711791 [No Abstract] [Full Text] [Related]
7. B-type natriuretic peptide and C-terminal-pro-endothelin-1 for the prediction of severely impaired peak oxygen consumption. Maeder MT; Brutsche MH; Staub D; Morgenthaler NG; Bergmann A; Noveanu M; Laule K; Breidthardt T; Christ A; Klima T; Reichlin T; Potocki M; Mueller C J Intern Med; 2009 May; 265(5):604-15. PubMed ID: 19226375 [TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta 1 as a biomarker of diabetic peripheral neuropathy: cross-sectional study. Ybarra J; Pou JM; Romeo JH; Merce J; Jurado J J Diabetes Complications; 2010; 24(5):306-12. PubMed ID: 19796969 [TBL] [Abstract][Full Text] [Related]
9. Amino-terminal pro-B-type natriuretic peptides: testing in general populations. de Lemos JA; Hildebrandt P Am J Cardiol; 2008 Feb; 101(3A):16-20. PubMed ID: 18243852 [TBL] [Abstract][Full Text] [Related]
10. Exercise training improves glycemic control in long-standing insulin-treated type 2 diabetic patients. De Feyter HM; Praet SF; van den Broek NM; Kuipers H; Stehouwer CD; Nicolay K; Prompers JJ; van Loon LJ Diabetes Care; 2007 Oct; 30(10):2511-3. PubMed ID: 17626892 [No Abstract] [Full Text] [Related]
11. Plasma N-terminal Pro-Brain Natriuretic Peptide (Nt-proBNP) level and prognosis after myocardial infarction in diabetes. Vergès B; Zeller M; Beer JC; Cottin Y; Diabetes Metab; 2008 Feb; 34 Suppl 1():S10-5. PubMed ID: 18358421 [TBL] [Abstract][Full Text] [Related]
12. Natriuretic peptide concentrations in centenarians. Nybo M; Jeune B; Andersen-Ranberg K J Am Geriatr Soc; 2012 May; 60(5):991-3. PubMed ID: 22587866 [No Abstract] [Full Text] [Related]
13. Developing the utility of blood biomarker associations beyond population sample linkage to events in cardiovascular patients. Macfadyen RJ; Ng Kam Chuen MJ Eur Heart J; 2008 Apr; 29(7):837-9. PubMed ID: 18334472 [No Abstract] [Full Text] [Related]
14. Aminoterminal natriuretic peptides and cardiovascular risk in an Italian male adult cohort. Barbato A; Sciarretta S; Marchitti S; Iacone R; Di Castro S; Stanzione R; Cotugno M; Ippolito R; Palmieri L; Calvieri C; Battistoni A; Volpe M; Strazzullo P; Rubattu S; Int J Cardiol; 2011 Oct; 152(2):245-6. PubMed ID: 21862156 [No Abstract] [Full Text] [Related]
15. Comment on Hillis et al. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic Peptide to predict cardiovascular events and death in patients with type 2 diabetes. Diabetes care 2014;37:295-303. Neuhold S; Pacher R; Hülsmann M Diabetes Care; 2014 Jun; 37(6):e152-3. PubMed ID: 24855180 [No Abstract] [Full Text] [Related]
16. Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population. Sung SH; Chuang SY; Sheu WH; Lee WJ; Chou P; Chen CH Am J Cardiol; 2009 May; 103(10):1411-6. PubMed ID: 19427438 [TBL] [Abstract][Full Text] [Related]
17. Response to comment on Hillis et al. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic Peptide to predict cardiovascular events and death in patients with type 2 diabetes. Diabetes care 2014;37:295-303. Hillis GS; Welsh P; Chalmers J; Woodward M; Sattar N Diabetes Care; 2014 Jun; 37(6):e154. PubMed ID: 24855181 [No Abstract] [Full Text] [Related]
18. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure. Januzzi JL; Bayes-Genis A Drug News Perspect; 2009 Jun; 22(5):267-73. PubMed ID: 19609464 [TBL] [Abstract][Full Text] [Related]
19. Biomarker sensitivity and specificity require pre-test probability of disease diagnosis to be collated: additional points on the interpretation of pro-B-type natriuretic peptide triage of dyspnea in the Copenhagen Heart Study. MacFadyen RJ; Chuen MJ J Am Coll Cardiol; 2008 Apr; 51(13):1322-3; author reply 1323. PubMed ID: 18371568 [No Abstract] [Full Text] [Related]